Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 2,260

Solved: Fluid Mechanics Mystery That’s Been Puzzling Scientists for Decades

An Oregon State University environmental engineering professor has solved a decades-old mystery regarding the behavior of fluids, a field of study with widespread medical, industrial, and environmental applications.

The research by Brian D. Wood, published in the Journal of Fluid Mechanics, clears a roadblock that has been puzzling scientific minds for nearly 70 years and paves the way to a clearer picture of how chemicals mix in fluids.

A more complete grasp of that basic principle provides a foundation for advances in a range of areas – from how pollutants spread in the atmosphere to how drugs perfuse tissues within the human body.

Sugar coating locks and loads coronavirus for infection

They say you can’t judge a book by its cover. But the human immune system does just that when it comes to finding and attacking harmful microbes such as the coronavirus. It relies on being able to recognize foreign intruders and generate antibodies to destroy them. Unfortunately, the coronavirus uses a sugary coating of molecules called glycans to camouflage itself as harmless from the defending antibodies.

Simulations on the National Science Foundation (NSF)-funded Frontera supercomputer at the Texas Advanced Computing Center (TACC) have revealed the atomic makeup of the coronavirus’s sugary shield. What’s more, simulation and modeling show that glycans also prime the coronavirus for infection by changing the shape of its spike . Scientists hope this basic research will add to the arsenal of knowledge needed to defeat the COVID-19 virus.

Sugar-like molecules called glycans coat each of the 65-odd spike proteins that adorn the coronavirus. Glycans account for about 40 percent of the spike protein by weight. The spike proteins are critical to cell infection because they lock onto the , giving the virus entry into the cell.

How decoding the brain can heal anxiety and restore sensations

While modern, scientific understanding of this complex network of neurons between our ears really only began in the last few decades, we’ve already learned a lot about the body’s control center — and have been given a lot to think about.

In this episode of The Abstract, we discuss the groundbreaking research in brain-computer technology offering new hope in restoring sensations and treating anxiety.

Our first story is about groundbreaking research in brain-computer interfaces that’s offering new hope for those who have lost their sense of touch. By decoding neural signals from the brain, researchers were able to create movement and sensory perception in paralyzed limbs. Innovations like these in sense-restoring technology could be life-changing for spinal cord patients and make a devastating loss of sensation reversible.

From bacteria to you: The biological reactions that sustain our rhythms

Every second of every day, countless biochemical reactions take place in our bodies’ cells. The organization of this complex system is the result of billions of years of evolution, fine-tuning our functions since the first primordial organisms.

One such vital reaction is “methylation,” where a —a carbon atom linked to three hydrogen atoms—attaches itself to a target molecule. Methylation is involved in the regulation of everything from DNA to proteins, and it is so vital that it can be found in all .

In a recent paper published in Communications Biology, a team of researchers lead by Jean-Michel Fustin and Hitoshi Okamura from Kyoto University’s Graduate School of Pharmaceutical Sciences has uncovered an intimate connection between methylation and the body’s circadian rhythms: a link that exists even in organisms that don’t traditionally “sleep,” such as bacteria.

Night owls have more grey matter in their brains than early birds

Being a late-riser suggests you could have more grey matter in your brain, a study from Brunel University London has shown.

A new survey of thousands of MRI scans revealed that people with a preference for waking up in the late hours of one morning, and going to bed in the early hours of the next, are likely to have a higher volume of in their precuneus, a key area of the associated with .

Previous studies have shown that lower volumes of grey matter are associated with how empathetic or cooperative a person is, traits that scientists have also previously found correlate with being an early bird, suggesting such personality traits could be underpinned by a physical signature.

Researchers Identify 126,018 Human Genetic Variations

A team of scientists from the Wellcome Sanger Institute, the Francis Crick Institute, and EMBL-EBI has created a comprehensive structural variation atlas for a geographically diverse set of human genomes and recovered sequences missing from the human reference sequence. Among the 126,018 structural variations discovered by the team were medically-important genes in Oceanian populations that were inherited from Denisovans, a sister group to Neanderthals.

Researchers identify new approach to turning on the heat in energy-burning fat cells

Researchers have discovered a new set of signals that cells send and receive to prompt one type of fat cell to convert fat into heat. The signaling pathway, discovered in mice, has potential implications for activating this same type of thermogenic fat in humans.

Thermogenic fat , also called beige fat or beige adipocytes, have gained attention in recent years for their potential to curb obesity and other metabolic disorders, due to their ability to burn energy stored as fat. But scientists have yet to translate this potential into effective therapies.

The challenge of activating beige fat in humans arises, in part, because this process is regulated through so-called adrenergic signaling, which uses the hormone catecholamine to instruct beige fat cells to start burning energy. But adrenergic signaling also controls other important biological functions, including and heartbeat regulation, so activating it in humans with agonists has potentially dangerous side effects.

New Bionic Eye Might See Better Than We Do

The ability to restore sight to the blind is one of the most profound acts of healing medicine can achieve, in terms of the impact on the affected patient’s life — and one of the most difficult for modern medicine to achieve. We can restore vision in a limited number of scenarios and there are some early bionic eyes on the market that can restore limited vision in very specific scenarios. Researchers may have taken a dramatic step towards changing that in the future, with the results of a new experiment to design a bionic retina.

The research team in question has published a paper in Nature detailing the construction of a hemispherical retina built out of high-density nanowires. The spherical shape of the retina has historically been a major challenge for biomimetic devices.

EyeComparison

David Sinclair on Aging and How we can reset our age

Good talk, not just about NAD. Q&A just before 35 minutes. A lot of epigenetics here.

David A. Sinclair, Ph.D., A.O. is a Professor in the Department of Genetics and co-Director of the Paul F. Glenn Center for the Biology of Aging at Harvard Medical School. He is best known for his work on understanding why we age and how to slow its effects. He obtained his Ph.D. in Molecular Genetics at the University of New South Wales, Sydney in 1995. He worked as a postdoctoral researcher at M.I.T. with Dr. Leonard Guarente where he co discovered a cause of aging for yeast as well as the role of Sir2 in epigenetic changes driven by genome instability. In 1999 he was recruited to Harvard Medical School where he has been teaching aging biology and translational medicine for aging for the past 16 years. His research has been primarily focused on the sirtuins, protein-modifying enzymes that respond to changing NAD+ levels and to caloric restriction (CR) with associated interests in chromatin, energy metabolism, mitochondria, learning and memory, neurodegeneration, and cancer. The Sinclair lab was the first one to identify a role for NAD+ biosynthesis in regulation of lifespan and first showed that sirtuins are involved in CR in mammals. They first identified small molecules that activate SIRT1 such as resveratrol and studied how they improve metabolic function using a combination of genetic, enzymological, biophysical and pharmacological approaches. They recently showed that natural and synthetic activators require SIRT1 to mediate the in vivo effects in muscle and identified a structured activation domain. They demonstrated that miscommunication between the mitochondrial and nuclear genomes is a cause of age-related physiological decline and that relocalization of chromatin factors in response to DNA breaks may be a cause of aging.

Israeli researchers explain how they are healing the world with precision

Data governs our lives more than ever. But when it comes to disease and death, every data point is a person, someone who became sick and needed treatment.

Recent studies have revealed that people suffering from the same disease category may have different manifestations. As doctors and scientists better understand the reasons underlying this variability, they can develop novel preventive, diagnostic and therapeutic approaches and provide optimal, personalized care for every patient.

To accomplish this goal often requires broadscale collaborations between physicians, basic researchers, theoreticians, experimentalists, computational biologists, computer scientists and data scientists, engineers, statisticians, epidemiologists and others. They must work together to integrate scientific and medical knowledge, theory, analysis of medical big data and extensive experimental work.

This year, the Israel Precision Medicine Partnership (IPMP) selected 16 research projects to receive NIS 60 million in grants with the goal of advancing the implementation of personalized healthcare approaches – providing the right treatment to the right patient at the right time. All the research projects pull data from Israel’s unique and vast medical databases.

HEALTH AND SCIENCE AFFAIRS: 16 Israeli projects get NIS 60m. to innovate next stage of healthcare.

/* */